Huntington National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.8M | Sell |
27,754
-1,369
| -5% | -$607K | 0.07% | 189 |
|
|
2026
Q1 | $13M | Sell |
29,123
-3,876
| -12% | -$1.81M | 0.07% | 192 |
|
|
2025
Q4 | $15M | Buy |
32,999
+3,552
| +12% | +$1.53M | 0.09% | 158 |
|
|
2025
Q3 | $11.5M | Sell |
29,447
-3,965
| -12% | -$1.66M | 0.07% | 183 |
|
|
2025
Q2 | $14.9M | Sell |
33,412
-2,356
| -7% | -$1.09M | 0.1% | 152 |
|
|
2025
Q1 | $17.3M | Sell |
35,768
-2,618
| -7% | -$1.22M | 0.13% | 142 |
|
|
2024
Q4 | $15.5M | Sell |
38,386
-843
| -2% | -$391K | 0.11% | 149 |
|
|
2024
Q3 | $18.2M | Sell |
39,229
-1,118
| -3% | -$537K | 0.13% | 142 |
|
|
2024
Q2 | $18.9M | Sell |
40,347
-5,850
| -13% | -$2.54M | 0.15% | 138 |
|
|
2024
Q1 | $19.3M | Sell |
46,197
-20,632
| -31% | -$8.72M | 0.16% | 137 |
|
|
2023
Q4 | $27.2M | Sell |
66,829
-52,806
| -44% | -$19.5M | 0.25% | 102 |
|
|
2023
Q3 | $41.6M | Buy |
119,635
+7,616
| +7% | +$2.66M | 0.42% | 67 |
|
|
2023
Q2 | $39.4M | Buy |
112,019
+102,249
| +1,047% | +$34.5M | 0.37% | 74 |
|
|
2023
Q1 | $3.08M | Buy |
9,770
+5,611
| +135% | +$1.68M | 0.03% | 267 |
|
|
2022
Q4 | $1.2M | Buy |
4,159
+560
| +16% | +$171K | 0.01% | 359 |
|
|
2022
Q3 | $1.04M | Sell |
3,599
-118
| -3% | -$34K | 0.01% | 363 |
|
|
2022
Q2 | $1.05M | Sell |
3,717
-361
| -9% | -$96.6K | 0.01% | 371 |
|
|
2022
Q1 | $1.06M | Sell |
4,078
-209
| -5% | -$49.6K | 0.01% | 382 |
|
|
2021
Q4 | $941K | Sell |
4,287
-1,026
| -19% | -$200K | 0.01% | 400 |
|
|
2021
Q3 | $962K | Sell |
5,313
-441
| -8% | -$86.1K | 0.01% | 386 |
|
|
2021
Q2 | $1.16M | Buy |
5,754
+4,746
| +471% | +$993K | 0.01% | 362 |
|
|
2021
Q1 | $217K | Buy |
1,008
+39
| +4% | +$8.57K | ﹤0.01% | 506 |
|
|
2020
Q4 | $229K | Sell |
969
-613
| -39% | -$141K | ﹤0.01% | 476 |
|
|
2020
Q3 | $431K | Sell |
1,582
-122
| -7% | -$33.7K | 0.01% | 386 |
|
|
2020
Q2 | $495K | Sell |
1,704
-26
| -2% | -$7.05K | 0.01% | 373 |
|
|
2020
Q1 | $411K | Buy |
1,730
+580
| +50% | +$133K | 0.01% | 384 |
|
|
2019
Q4 | $253K | Buy |
1,150
+548
| +91% | +$111K | ﹤0.01% | 488 |
|
|
2019
Q3 | $102K | Buy |
602
+31
| +5% | +$5.48K | ﹤0.01% | 649 |
|
|
2019
Q2 | $106K | Buy |
571
+6
| +1% | +$1.05K | ﹤0.01% | 655 |
|
|
2019
Q1 | $104K | Sell |
565
-210
| -27% | -$38.8K | ﹤0.01% | 673 |
|
|
2018
Q4 | $128K | Buy |
775
+112
| +17% | +$19.4K | ﹤0.01% | 595 |
|
|
2018
Q3 | $128K | Buy |
663
+230
| +53% | +$41K | ﹤0.01% | 654 |
|
|
2018
Q2 | $73K | Sell |
433
-379
| -47% | -$58.7K | ﹤0.01% | 824 |
|
|
2018
Q1 | $132K | Buy |
812
+347
| +75% | +$56.7K | ﹤0.01% | 672 |
|
|
2017
Q4 | $70K | Sell |
465
-16
| -3% | -$2.37K | ﹤0.01% | 881 |
|
|
2017
Q3 | $73K | Buy |
481
+212
| +79% | +$31.9K | ﹤0.01% | 872 |
|
|
2017
Q2 | $35K | Buy |
269
+225
| +511% | +$27.1K | ﹤0.01% | 1034 |
|
|
2017
Q1 | $5K | Buy |
+44
| New | +$3.87K | ﹤0.01% | 1267 |
|
|
2016
Q4 | – | Sell |
-30
| Closed | -$3K | – | 1520 |
|
|
2016
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 1419 |
|
|
2016
Q2 | $3K | Sell |
30
-50
| -63% | -$4.32K | ﹤0.01% | 1393 |
|
|
2016
Q1 | $9K | Sell |
80
-74
| -48% | -$6.69K | ﹤0.01% | 1485 |
|
|
2015
Q4 | $19K | Buy |
154
+22
| +17% | +$2.66K | ﹤0.01% | 1251 |
|
|
2015
Q3 | $14K | Buy |
132
+32
| +32% | +$4.11K | ﹤0.01% | 1366 |
|
|
2015
Q2 | $12K | Buy |
100
+20
| +25% | +$2.52K | ﹤0.01% | 1465 |
|
|
2015
Q1 | $9K | Buy |
80
+8
| +11% | +$959 | ﹤0.01% | 1495 |
|
|
2014
Q4 | $9K | Buy |
+72
| New | +$8.11K | ﹤0.01% | 1469 |
|
|
2014
Q1 | – | Sell |
-402
| Closed | -$30K | – | 1542 |
|
|
2013
Q4 | $30K | Buy |
402
+1
| +0.2% | +$70 | ﹤0.01% | 1239 |
|
|
2013
Q3 | $30K | Sell |
401
-56
| -12% | -$4.46K | ﹤0.01% | 1211 |
|
|
2013
Q2 | $37K | Buy |
+457
| New | +$33.7K | ﹤0.01% | 1135 |
|
Other funds holding VRTX
Huntington National Bank's VRTX Position: Q2 2026 in Review
Huntington National Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 4.7% in Q2 2026, selling an estimated $607K and leaving 27,754 shares worth $13.8M. The position accounts for 0.07% of the portfolio, ranked #189.
Huntington National Bank first reported a position in VRTX in Q2 2013 and has held it in 49 quarters since. The position peaked at $41.6M in Q3 2023. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Huntington National Bank held 27,754 shares of Vertex Pharmaceuticals worth $13.8M as of Q2 2026.
- Huntington National Bank sold 1,369 Vertex Pharmaceuticals shares in Q2 2026, an estimated $607K.
- Vertex Pharmaceuticals made up 0.07% of Huntington National Bank's portfolio in Q2 2026, its #189 holding.
- Huntington National Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 49 quarters since.
- Huntington National Bank's Vertex Pharmaceuticals position peaked at $41.6M in Q3 2023.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.